Reply

J Hypertens. 2017 Dec;35(12):2549-2550. doi: 10.1097/HJH.0000000000001549.

Authors

Chieh-Kai Chan¹, Tai-Shuan Lai, VinCent Wu; TAIPAI Study Group

Affiliation

¹ aDepartment of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Hsinchu County bDepartment of Internal Medicine, National Taiwan University Hospital cTaiwan Primary Aldosteronism Investigation (TAIPAI) Study Group, Taipei, Taiwan.

PMID: 29095233
DOI: 10.1097/HJH.0000000000001549

No abstract available

Publication types

Comment

MeSH terms

Cushing Syndrome*
Diabetes Mellitus
Humans
Hydrocortisone*
Hyperaldosteronism
Risk

Substances

Hydrocortisone